Modulatory effect of three probiotic strains on infantsâ gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study
In: Beneficial MicrobesSearch for other papers by J. De Andrés in
Current site
Google Scholar
Probisearch S.L.U., C/Santiago GrisolÃa, 2, 28760 Tres Cantos, Spain.
Search for other papers by S. Manzano in
Current site
Google Scholar
Search for other papers by C. GarcÃa in
Current site
Google Scholar
Search for other papers by J.M. RodrÃguez in
Current site
Google Scholar
Search for other papers by I. Espinosa-Martos in
Current site
Google Scholar
Probisearch S.L.U., C/Santiago GrisolÃa, 2, 28760 Tres Cantos, Spain.
Search for other papers by E. Jiménez in
Current site
Google Scholar
The gut microbiota plays a crucial role in gastrointestinal health. Current use of probiotics is aimed at modulating the bacterial gut composition to alleviate specific diseases. The safety and tolerance of three probiotic strains (Bifidobacterium longum subsp. infantis R0033, Lactobacillus helveticus R0052 and Bifidobacterium bifidum R0071) has recently been described. The objective of the present study was to analyse the microbiological composition and immunological parameters of faecal samples obtained from healthy infants from 3 to 12 months of age after receiving either one of the three probiotic strains or placebo for 8 weeks. 16S ribosomal RNA gene sequencing and multiplexing technology was used for analysis. Faecal sample analysis showed that the most abundant genus in all four groups of infants pre- and post-intervention was Bifidobacterium, representing approximately 50% of the sequences. After the intervention period the microbial composition of faecal samples in the probiotic groups did not display notable changes. In contrast, a decrease in different Bifidobacterium species, such as B. bifidum and Bifidobacterium breve and an increase in Bacteroides, Blautia, Clostridium, Coprococcus and Faecalibacterium genera was observed in the placebo group. The analysis of a wide range of immune factors in faecal samples suggests a modulatory effect by these three probiotic strains during the intervention period. The anti-inflammatory ratio interleukin (IL)-10/IL-12 increased at the end of the intervention period in the B. infantis R0033 group while the TNF-α/IL-10 ratio increased in the L. helveticus R0052 group. The decrease of the IL-10/IL-12 ratio together with the increase of the tumour necrosis factor alpha (TNF-α)/IL-10 ratio demonstrated a pro-inflammatory profile in the placebo group. In conclusion, the species profile of the microbiome observed in all three probiotic groups resembled that of a younger infant, similar to an unweaned infant, when compared to the placebo group which may also be related with an anti-inflammatory effect.
-
Abrahamsson, T.R., Sinkiewicz, G., Jakobsson, T., Fredrikson, M. and Bjorksten, B., 2009. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. Journal of Pediatric Gastroenterology and Nutrition 49: 349-354.
'Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life ' () 49 Journal of Pediatric Gastroenterology and Nutrition : 349 -354.
-
Berni Canani, R., Sangwan, N., Stefka, A.T., Nocerino, R., Paparo, L., Aitoro, R., Calignano, A., Khan, A.A., Gilbert, J.A. and Nagler, C.R., 2016. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME Journal 10: 742-750.
'Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants ' () 10 ISME Journal : 742 -750.
-
Blanco-Quiros, A., Arranz, E., Solis, G., Villar, A., Ramos, A. and Coto, D., 2000. Cord blood interleukin-10 levels are increased in preterm newborns. European Journal of Pediatrics 159: 420-423.
'Cord blood interleukin-10 levels are increased in preterm newborns ' () 159 European Journal of Pediatrics : 420 -423.
-
Campeotto, F., Suau, A., Kapel, N., Magne, F., Viallon, V., Ferraris, L., Waligora-Dupriet, A.J., Soulaines, P., Leroux, B., Kalach, N., Dupont, C. and Butel, M.J., 2011. A fermented formula in preterm infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. British Journal of Nutrition 105: 1843-1851.
'A fermented formula in preterm infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA ' () 105 British Journal of Nutrition : 1843 -1851.
-
Cheng, J., Ringel-Kulka, T., Heikamp-de Jong, I., Ringel, Y., Carroll, I., de Vos, W.M., Salojarvi, J. and Satokari, R., 2016. Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME Journal 10: 1002-1014.
'Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children ' () 10 ISME Journal : 1002 -1014.
-
DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Huber, T., Dalevi, D., Hu, P. and Andersen, G.L., 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and Environmental Microbiology 72: 5069-5072.
'Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB ' () 72 Applied and Environmental Microbiology : 5069 -5072.
-
Dore, J., Ehrlich, S.D., Levenez, F., Pelletier, E., Alberti, A., Bertrand, L., Bork, P., Costea, P.I., Sunagawa, S., Guarner, F., Manichanh, C., Santiago, A., Zhao, L., Shen, J., Zhang, C., Versalovic, J., Luna, R.A., Petrosino, J., Yang, H., Li, S., Wang, J., Allen-Vercoe, E., Gloor, G., Singh, B. and IHMS Consortium, 2015. IHMS_SOP 06 V1: Standard operating procedure for faecal samples DNA extraction, Protocol Q. International Human Microbiome Standards. Available at: http://www.microbiome-standards.org.
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: http://tinyurl.com/zdbrkeg.
-
Francino, M.P., 2014. Early development of the gut microbiota and immune health. Pathogens 3: 769-790.
'Early development of the gut microbiota and immune health ' () 3 Pathogens : 769 -790.
-
Gil-Campos, M., López, M.Ã., Rodriguez-BenÃtez, M.V., Romero, J., Roncero, I., Linares, M.D., Maldonado, J., López-Huertas, E., Berwind, R., Ritzenthaler, K.L., Navas, V., Sierra, C., Sempere, L., Geerlings, A., Maldonado-Lobón, J.A., Valero, A.D., Lara-Villoslada, F. and Olivares, M., 2012. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacological Research 65: 231-238.
'Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial ' () 65 Pharmacological Research : 231 -238.
-
Hart, A.L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M.A., Knight, S.C. and Stagg, A.J., 2004. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53: 1602-1609.
'Modulation of human dendritic cell phenotype and function by probiotic bacteria ' () 53 Gut : 1602 -1609.
-
Hatakka, K., Savilahti, E., Ponka, A., Meurman, J.H., Poussa, T., Nase, L., Saxelin, M. and Korpela, R., 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322: 1327.
'Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial ' () 322 BMJ : 1327.
-
Hevia, A., Delgado, S., Sánchez, B. and Margolles, A., 2015. Molecular players involved in the interaction between beneficial bacteria and the immune system. Frontiers in Microbiology 6: 1285.
'Molecular players involved in the interaction between beneficial bacteria and the immune system ' () 6 Frontiers in Microbiology : 1285.
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506.
'The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic ' () 11 Nature Reviews Gastroenterology and Hepatology : 506.
-
Holscher, H.D., Czerkies, L.A., Cekola, P., Litov, R., Benbow, M., Santema, S., Alexander, D.D., Perez, V., Sun, S., Saavedra, J.M. and Tappenden, K.A., 2012. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. Journal of Parenteral and Enteral Nutrition 36: 106S-117S.
'Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial ' () 36 Journal of Parenteral and Enteral Nutrition : 106S -117S.
-
Johansson, M.A., Saghafian-Hedengren, S., Haileselassie, Y., Roos, S., Troye-Blomberg, M., Nilsson, C. and Sverremark-Ekstrom, E., 2012. Early-life gut bacteria associate with IL-4-, IL-10- and IFN-gamma production at two years of age. PLoS One 7: e49315.
'Early-life gut bacteria associate with IL-4-, IL-10- and IFN-gamma production at two years of age ' () 7 PLoS One : e49315.
-
Kapel, N., Campeotto, F., Kalach, N., Baldassare, M., Butel, M.J. and Dupont, C., 2010. Faecal calprotectin in term and preterm neonates. Journal of Pediatric Gastroenterology and Nutrition 51: 542-547.
'Faecal calprotectin in term and preterm neonates ' () 51 Journal of Pediatric Gastroenterology and Nutrition : 542 -547.
-
Klaassens, E.S., Boesten, R.J., Haarman, M., Knol, J., Schuren, F.H., Vaughan, E.E. and de Vos, W.M., 2009. Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants. Applied and Environmental Microbiology 75: 2668-2676.
'Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants ' () 75 Applied and Environmental Microbiology : 2668 -2676.
-
Klemenak, M., Dolinsek, J., Langerholc, T., Di Gioia, D. and Micetic-Turk, D., 2015. Administration of Bifidobacterium breve decreases the production of TNF-alpha in children with celiac disease. Digestive Diseases and Sciences 60: 3386-3392.
'Administration of Bifidobacterium breve decreases the production of TNF-alpha in children with celiac disease ' () 60 Digestive Diseases and Sciences : 3386 -3392.
-
Konikoff, M.R. and Denson, L.A., 2006. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflammatory Bowel Diseases 12: 524-534.
'Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease ' () 12 Inflammatory Bowel Diseases : 524 -534.
-
Kullen, M.J., Sanozky-Dawes, R.B., Crowell, D.C. and Klaenhammer, T.R., 2000. Use of the DNA sequence of variable regions of the 16S rRNA gene for rapid and accurate identification of bacteria in the Lactobacillus acidophilus complex. Journal of Applied Microbiology 89: 511-516.
'Use of the DNA sequence of variable regions of the 16S rRNA gene for rapid and accurate identification of bacteria in the Lactobacillus acidophilus complex ' () 89 Journal of Applied Microbiology : 511 -516.
-
Lagier, J.C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.F., Koonin, E.V., La Scola, B. and Raoult, D., 2012. Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiological Infection 18: 1185-1193.
'Microbial culturomics: paradigm shift in the human gut microbiome study ' () 18 Clinical Microbiological Infection : 1185 -1193.
-
Lahtinen, S.J., Boyle, R.J., Kivivuori, S., Oppedisano, F., Smith, K.R., Robins-Browne, R., Salminen, S.J. and Tang, M.L.K., Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. Journal of Allergy and Clinical Immunology 123: 499-501.e498.
'Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy ' () 123 Journal of Allergy and Clinical Immunology : 499 -501.
-
Lusyati, S., Hulzebos, C.V., Zandvoort, J., Sukandar, H. and Sauer, P.J., 2013. Cytokines patterns in newborn infants with late onset sepsis. Journal of Neonatal-Perinatal Medicine 6: 153-163.
'Cytokines patterns in newborn infants with late onset sepsis ' () 6 Journal of Neonatal-Perinatal Medicine : 153 -163.
-
Maldonado, J., Lara-Villoslada, F., Sierra, S., Sempere, L., Gomez, M., Rodriguez, J.M., Boza, J., Xaus, J. and Olivares, M., 2010. Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children. Nutrition 26: 1082-1087.
'Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children ' () 26 Nutrition : 1082 -1087.
-
Maldonado-Lobon, J.A., Gil-Campos, M., Maldonado, J., Lopez-Huertas, E., Flores-Rojas, K., Valero, A.D., Rodriguez-Benitez, M.V., Banuelos, O., Lara-Villoslada, F., Fonolla, J. and Olivares, M., 2015. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial. Pharmacological Research 95-96: 12-19.
'Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial ' () 96 Pharmacological Research : 12 -19.
-
Manzano, S., De Andres, J., Castro, I., Rodriguez, J.M., Jimenez, E. and Espinosa-Martos, I., 2017. Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial. Beneficial Microbes 8: 569-578.
'Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial ' () 8 Beneficial Microbes : 569 -578.
-
Matamoros, S., Gras-Leguen, C., Le Vacon, F., Potel, G. and de La Cochetiere, M.F., 2013. Development of intestinal microbiota in infants and its impact on health. Trends in Microbiology 21: 167-173.
'Development of intestinal microbiota in infants and its impact on health ' () 21 Trends in Microbiology : 167 -173.
-
Matoba, N., Yu, Y., Mestan, K., Pearson, C., Ortiz, K., Porta, N., Thorsen, P., Skogstrand, K., Hougaard, D.M., Zuckerman, B. and Wang, X., 2009. Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics 123: 1320-1328.
'Differential patterns of 27 cord blood immune biomarkers across gestational age ' () 123 Pediatrics : 1320 -1328.
-
Maynard, C.L., Elson, C.O., Hatton, R.D. and Weaver, C.T., 2012. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489: 231-241.
'Reciprocal interactions of the intestinal microbiota and immune system ' () 489 Nature : 231 -241.
-
Mentula, S., Tuure, T., Koskenala, R., Korpela, R. and Könönen, E., 2008. Microbial composition and fecal fermentation end products from colicky infants â a probiotic supplementation pilot. Microbial Ecology in Health and Disease 20: 37-47.
'Microbial composition and fecal fermentation end products from colicky infants â a probiotic supplementation pilot ' () 20 Microbial Ecology in Health and Disease : 37 -47.
-
Mohan, R., Koebnick, C., Schildt, J., Schmidt, S., Mueller, M., Possner, M., Radke, M. and Blaut, M., 2006. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. Journal of Clinical Microbiology 44: 4025-4031.
'Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study ' () 44 Journal of Clinical Microbiology : 4025 -4031.
-
Moles, L., Escribano, E., De Andres, J., Montes, M.T., Rodriguez, J.M., Jimenez, E., Seanz de Pipaon, M. and Espinosa-Martos, I., 2015. Administration of Bifidobacterium breve PS12929 and Lactobacillus salivarius PS12934, two strains isolated from human milk, to very low and extremely low birth weight preterm infants: a pilot study. Journal of Immunology Research 2015: 12.
'Administration of Bifidobacterium breve PS12929 and Lactobacillus salivarius PS12934, two strains isolated from human milk, to very low and extremely low birth weight preterm infants: a pilot study ' () 2015 Journal of Immunology Research : 12.
-
Olivares, M., Castillejo, G., Varea, V. and Sanz, Y., 2014. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. British Journal of Nutrition 112: 30-40.
'Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease ' () 112 British Journal of Nutrition : 30 -40.
-
Plaza-Diaz, J., Gomez-Llorente, C., Campana-Martin, L., Matencio, E., Ortuno, I., Martinez-Silla, R., Gomez-Gallego, C., Periago, M.J., Ros, G., Chenoll, E., Genoves, S., Casinos, B., Silva, A., Corella, D., Portoles, O., Romero, F., Ramon, D., Perez de la Cruz, A., Gil, A. and Fontana, L., 2013. Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study. PLoS One 8: e78111.
'Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study ' () 88 PLoS One : e78111.
-
ProkeÅ¡ová, L., Lodinová-ŽádnÃková, R., Žižka, J., Kocourková, I., Novotná, O., Petrásková, P. and Å terzl, I., 2006. Cytokine levels in healthy and allergic mothers and their children during the first year of life. Pediatric Allergy and Immunology 17: 175-183.
'Cytokine levels in healthy and allergic mothers and their children during the first year of life ' () 17 Pediatric Allergy and Immunology : 175 -183.
-
Rijkers, G.T., De Vos, W.M., Brummer, R.J., Morelli, L., Corthier, G. and Marteau, P., 2011. Health benefits and health claims of probiotics: bridging science and marketing. British Journal of Nutrition 106: 1291-1296.
'Health benefits and health claims of probiotics: bridging science and marketing ' () 106 British Journal of Nutrition : 1291 -1296.
-
Ringel-Kulka, T., Cheng, J., Ringel, Y., Salojarvi, J., Carroll, I., Palva, A., de Vos, W.M. and Satokari, R., 2013. Intestinal microbiota in healthy U.S. young children and adults--a high throughput microarray analysis. PLoS One 8: e64315.
'Intestinal microbiota in healthy U.S. young children and adults--a high throughput microarray analysis. ' () 8 PLoS One : e64315.
-
Rugtveit, J. and Fagerhol, M.K., 2002. Age-dependent variations in faecal calprotectin concentrations in children. Journal of Pediatric Gastroenterology and Nutrition 34: 323-325.
'Age-dependent variations in faecal calprotectin concentrations in children ' () 34 Journal of Pediatric Gastroenterology and Nutrition : 323 -325.
-
Scholtens, P.A.M.J., Alliet, P., Raes, M., Alles, M.S., Kroes, H., Boehm, G., Knippels, L.M.J., Knol, J. and Vandenplas, Y., 2008. Fecal secretory immunoglobulin a is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. Journal of Nutrition 138: 1141-1147.
'Fecal secretory immunoglobulin a is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides ' () 138 Journal of Nutrition : 1141 -1147.
-
Sierra, C., Bernal, M.J., Blasco, J., Martinez, R., Dalmau, J., Ortuno, I., Espin, B., Vasallo, M.I., Gil, D., Vidal, M.L., Infante, D., Leis, R., Maldonado, J., Moreno, J.M. and Roman, E., 2015. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. European Journal of Nutrition 54: 89-99.
'Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial ' () 54 European Journal of Nutrition : 89 -99.
-
Sjogren, Y.M., Tomicic, S., Lundberg, A., Bottcher, M.F., Bjorksten, B., Sverremark-Ekstrom, E. and Jenmalm, M.C., 2009. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clinical and Experimental Allergy 39: 1842-1851.
'Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses ' () 39 Clinical and Experimental Allergy : 1842 -1851.
-
Van de Ven, A.A., Janssen, W.J., Schulz, L.S., Van Loon, A.M., Voorkamp, K., Sanders, E.A., Kusters, J.G., Nierkens, S., Boes, M., Wensing, A.M. and Van Montfrans, J.M., 2014. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies. Journal of Clinical Immunology 34: 962-970.
'Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies ' () 34 Journal of Clinical Immunology : 962 -970.
-
Van Niel, C.W., 2005. Probiotics: not just for treatment anymore. Pediatrics 115: 174-177.
'Probiotics: not just for treatment anymore ' () 115 Pediatrics : 174 -177.
-
Wan, A.K., Seow, W.K., Purdie, D.M., Bird, P.S., Walsh, L.J. and Tudehope, D.I., 2003. Immunoglobulins in saliva of preterm and full-term infants. Oral Microbiology and Immunology 18: 72-78.
'Immunoglobulins in saliva of preterm and full-term infants ' () 18 Oral Microbiology and Immunology : 72 -78.
-
Wind, R.D., Tolboom, H., Klare, I., Huys, G. and Knol, J., 2010. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. British Journal of Nutrition 104: 1806-1816.
'Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers ' () 104 British Journal of Nutrition : 1806 -1816.
-
Wu, B.-B., Yang, Y., Xu, X. and Wang, W.-P., 2016. Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. World Journal of Pediatrics 12: 177-182.
'Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants ' () 12 World Journal of Pediatrics : 177 -182.
-
Zeissig, S. and Blumberg, R.S., 2014. Commensal microbial regulation of natural killer T cells at the frontiers of the mucosal immune system. FEBS Letters 588: 4188-4194.
'Commensal microbial regulation of natural killer T cells at the frontiers of the mucosal immune system ' () 588 FEBS Letters : 4188 -4194.
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 816 | 315 | 40 |
| PDF Views & Downloads | 945 | 460 | 28 |
Modulatory effect of three probiotic strains on infantsâ gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study
In: Beneficial MicrobesSearch for other papers by J. De Andrés in
Current site
Google Scholar
PubMed
Probisearch S.L.U., C/Santiago GrisolÃa, 2, 28760 Tres Cantos, Spain.
Search for other papers by S. Manzano in
Current site
Google Scholar
PubMed
Search for other papers by C. GarcÃa in
Current site
Google Scholar
PubMed
Search for other papers by J.M. RodrÃguez in
Current site
Google Scholar
PubMed
Search for other papers by I. Espinosa-Martos in
Current site
Google Scholar
PubMed
Probisearch S.L.U., C/Santiago GrisolÃa, 2, 28760 Tres Cantos, Spain.
Search for other papers by E. Jiménez in
Current site
Google Scholar
PubMed
The gut microbiota plays a crucial role in gastrointestinal health. Current use of probiotics is aimed at modulating the bacterial gut composition to alleviate specific diseases. The safety and tolerance of three probiotic strains (Bifidobacterium longum subsp. infantis R0033, Lactobacillus helveticus R0052 and Bifidobacterium bifidum R0071) has recently been described. The objective of the present study was to analyse the microbiological composition and immunological parameters of faecal samples obtained from healthy infants from 3 to 12 months of age after receiving either one of the three probiotic strains or placebo for 8 weeks. 16S ribosomal RNA gene sequencing and multiplexing technology was used for analysis. Faecal sample analysis showed that the most abundant genus in all four groups of infants pre- and post-intervention was Bifidobacterium, representing approximately 50% of the sequences. After the intervention period the microbial composition of faecal samples in the probiotic groups did not display notable changes. In contrast, a decrease in different Bifidobacterium species, such as B. bifidum and Bifidobacterium breve and an increase in Bacteroides, Blautia, Clostridium, Coprococcus and Faecalibacterium genera was observed in the placebo group. The analysis of a wide range of immune factors in faecal samples suggests a modulatory effect by these three probiotic strains during the intervention period. The anti-inflammatory ratio interleukin (IL)-10/IL-12 increased at the end of the intervention period in the B. infantis R0033 group while the TNF-α/IL-10 ratio increased in the L. helveticus R0052 group. The decrease of the IL-10/IL-12 ratio together with the increase of the tumour necrosis factor alpha (TNF-α)/IL-10 ratio demonstrated a pro-inflammatory profile in the placebo group. In conclusion, the species profile of the microbiome observed in all three probiotic groups resembled that of a younger infant, similar to an unweaned infant, when compared to the placebo group which may also be related with an anti-inflammatory effect.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 816 | 315 | 40 |
| PDF Views & Downloads | 945 | 460 | 28 |
